how many people use glp-1 drugs The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss 5 years ahead: How GLP-1

Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction

Estimates show that the typical employer could experience around a 50% increase in drug spend if half of the employees eligible for Wegovy were to take the drug

Finley eventually got her hands on the 17-page report and got a little help from ChatGPT to write an appeal, showing that the drug was necessary for her based on her diagnosis and covered under her policy

Response options included yes, significantly

Have been in private practice, education and inpatient medical director previously